For journalists and editors.

The Intelligence Companyfor the Molecule Economy.

Its Macro-connectionist Multi-Agent AI digitally clones patients' cells from mRNA data, simulates a drug's known targets inside them with more than 200,000 interacting agents, and predicts whether the drug will work, in whom, in which diseases and with which partner drug.

infinitusbio learns nothing from historical trials, so its reads carry no inherited bias, and every call is traced to its mechanism.

It serves pharma and biotech development teams, investors, deal teams and research groups.

Learn more at infinitusbio.ai.